Insider Transactions in Q3 2024 at Catalyst Pharmaceuticals, Inc. (CPRX)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 22
2024
|
Patrick J Mcenany Director |
SELL
Bona fide gift
|
Direct |
5,100
-0.11%
|
-
|
|
Aug 21
2024
|
David S Tierney Director |
SELL
Open market or private sale
|
Direct |
15,000
-4.12%
|
$300,000
$20.1 P/Share
|
|
Aug 21
2024
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+3.96%
|
$60,000
$4.01 P/Share
|
|
Aug 20
2024
|
Steve Miller Chief Op. & Scientific Officer |
SELL
Open market or private sale
|
Direct |
150,000
-6.47%
|
$3,000,000
$20.35 P/Share
|
|
Aug 15
2024
|
Patrick J Mcenany Director |
SELL
Bona fide gift
|
Direct |
45,000
-0.99%
|
-
|
|
Aug 09
2024
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct |
100,000
-66.05%
|
$1,800,000
$18.04 P/Share
|
|
Aug 09
2024
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+39.78%
|
$400,000
$4.01 P/Share
|
|
Aug 09
2024
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
36,058
-51.84%
|
$649,044
$18.43 P/Share
|
|
Aug 09
2024
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+41.45%
|
$60,000
$2.86 P/Share
|